You get a blood test. The doctor looks at the number, says it is too high, and hands you a statin prescription or a low-fat diet sheet. The conversation lasts four minutes. You leave with the strong impression that the cholesterol itself is the problem — that it has been accumulating in your arteries uninvited, and the goal is to get it down.
That framing has been consistent for half a century. The problem is that the original research supporting it was selectively reported, the dietary intervention trials failed to produce the predicted outcomes, and the mechanism — the biological reason cholesterol rises — points in a different direction entirely.
The body synthesises cholesterol deliberately, in quantities that dwarf dietary intake, because it performs functions with no substitutes. The productive question is why it is elevated in the first place.
What Cholesterol Does
Cholesterol is a structural and signalling molecule the body produces continuously in the liver. Every cell membrane in the body contains cholesterol — it regulates membrane fluidity, controls what enters and exits cells, and provides the structural rigidity that keeps cells intact under mechanical and chemical stress.
Beyond cell membranes, cholesterol is the precursor for every steroid hormone the body produces: cortisol, testosterone, oestrogen, progesterone, and aldosterone all synthesise from cholesterol. Vitamin D synthesis begins with cholesterol in the skin responding to ultraviolet light. Bile acids — required for fat digestion and the export of toxins from the liver — are synthesised from cholesterol. The myelin sheath insulating nerve fibres contains cholesterol. The brain, which accounts for roughly 2% of body weight, contains approximately 25% of the body's total cholesterol.
Cholesterol is also an antioxidant. LDL and HDL particles serve a specific immunological function: they neutralise lipopolysaccharides (LPS) — fragments from the cell walls of gram-negative bacteria that translocate from the gut into circulation and trigger systemic inflammation by activating TLR4 receptors on immune cells. When LPS enters the bloodstream, lipoproteins bind to it and facilitate its clearance through the liver. In conditions of chronic gut dysbiosis or high bacterial load, the body may raise lipoprotein production specifically to buffer this endotoxin exposure. This immune function of LDL is one reason very low cholesterol in elderly populations correlates with increased infection mortality rather than longevity benefit.
LDL particles also transport cholesterol to sites of cellular damage, where it is incorporated into membranes under repair. When oxidative damage is occurring in arterial walls or elsewhere, the liver increases cholesterol production and LDL dispatch to support the repair process. Elevated LDL is frequently a marker that repair demand has increased.
Why LDL Rises — The Oxidative Damage Model
The conventional model treats LDL as a cause: LDL deposits cholesterol in arterial walls, plaques form, arteries narrow, heart attacks follow. The mechanistic model tells a different story.
Arterial plaques form at sites of endothelial damage — injury to the cells lining the arterial wall. That damage has identifiable causes: oxidative stress from circulating free radicals, chronic low-grade inflammation, elevated blood glucose damaging arterial glycoproteins, homocysteine accumulation from B vitamin depletion, and mechanical stress from chronically elevated blood pressure.
At a damage site, the body mounts a repair response. LDL particles arrive carrying cholesterol and fat-soluble antioxidants. Macrophages engulf oxidised LDL at the damage site. Foam cells form. Plaques develop. The conventional model stops here and identifies LDL as the cause. The oxidative damage model identifies the endothelial injury as the cause — LDL arrived because damage was already present.
The distinction matters clinically. Reducing LDL through statins or dietary fat restriction addresses the repair response while the damage driving it continues. The arterial injury continues. The repair demand continues. The underlying cause continues undisturbed.
The specific pattern that supports the oxidative damage model: small, dense LDL particles — the subtype that accumulates most at arterial injury sites — are strongly associated with cardiovascular risk, while large, buoyant LDL particles show minimal association. Total LDL number is a poor predictor of cardiovascular events. Oxidised LDL, a direct marker of lipid peroxidation, is a substantially stronger predictor. This pattern is precisely what the oxidative damage model predicts and what the dietary cholesterol model struggles to explain.
What Drives the Oxidative Damage
If oxidative stress at the arterial wall drives the LDL response, the practical question is what generates that oxidative stress. Several specific mechanisms are well-documented.
Oxidised dietary fats
Polyunsaturated fats — particularly linoleic acid, the dominant fatty acid in seed oils — are chemically unstable under heat and metabolic processing. When linoleic acid oxidises, it generates reactive aldehydes including 4-hydroxynonenal (4-HNE) and malondialdehyde. These compounds damage arterial endothelium, deplete glutathione, and generate the oxidised LDL particles that accumulate at arterial injury sites.
The seed oil articles in the footer cover the sources and processing details. The relevant point here is the downstream mechanism: oxidised linoleic acid metabolites in circulation create the endothelial damage that LDL is subsequently dispatched to repair. The site of the problem is upstream of the cholesterol response.
Chronic elevated blood glucose
Glucose at chronically elevated levels glycates proteins — attaches to them chemically and impairs their function. Glycated LDL particles are more prone to oxidation than native LDL. Glycated arterial wall proteins create surface irregularities that trap LDL particles and initiate plaque formation. The connection between blood glucose dysregulation and cardiovascular risk is stronger than the connection between LDL and cardiovascular risk in most populations.
Omega-6 to omega-3 ratio
Omega-6 and omega-3 fatty acids compete for the same elongase and desaturase enzymes. The ratio in which they arrive determines which downstream eicosanoids the body produces. High omega-6 relative to omega-3 shifts production toward pro-inflammatory prostaglandins and leukotrienes. The chronic low-grade inflammation this produces is a direct driver of endothelial damage.
The ancestral omega-6 to omega-3 ratio is estimated at roughly 4:1. The ratio in populations eating standard Western diets runs between 15:1 and 20:1. This imbalance comes from seed oils displacing animal fats and providing a continuous high omega-6 load that the small amount of dietary omega-3 cannot balance.
High-potency omega-3 fish oil addresses the balance from both directions — the omega-3 intake rises while seed oil elimination reduces the omega-6 load.
Chronic stress and sleep deprivation
Cortisol from sustained stress raises blood glucose directly — elevating the glycation of LDL and arterial wall proteins that the glucose section above describes. Cortisol also depletes vitamin C and accelerates B vitamin turnover, simultaneously driving two of the other upstream damage mechanisms. The person eating a clean diet but running on chronic stress and poor sleep can produce an atherogenic environment through hormonal and metabolic routes that have nothing to do with food.
Sleep deprivation produces measurable increases in insulin resistance and inflammatory markers within days. People with persistently elevated cardiovascular markers despite good dietary habits frequently have disrupted sleep as an unaddressed driver. The inflammatory signalling that endothelial injury produces responds identically to oxidised dietary fats and cortisol-driven glucose elevation — both create the same downstream repair demand.
Oral bacteria and chronic endothelial inflammation
Gum disease — specifically periodontitis — creates a continuous source of bacterial inflammation that most cardiovascular risk assessments never consider. The same LPS mechanism described in the cholesterol function section operates here: oral gram-negative bacteria release lipopolysaccharides into the bloodstream, triggering systemic inflammatory signalling and endothelial damage through TLR4 receptor activation. The periodontal-cardiovascular connection is supported by multiple systematic reviews and meta-analyses showing people with gum disease have substantially higher rates of heart attack and stroke independent of other risk factors.
The practical implication is specific: someone managing diet and sleep and stress but neglecting chronic gum inflammation has an active upstream damage source that no dietary change addresses. Periodontal disease is treatable. It rarely appears in cardiovascular risk conversations.
Vitamin C deficiency and arterial micro-cracks
Vitamin C is required for collagen hydroxylation — the chemical process that gives collagen fibres their structural integrity. When vitamin C is insufficient, collagen fibres form with structural defects, and blood vessel walls, which depend on collagen for their structure, develop micro-cracks. The body dispatches cholesterol and calcium to repair those cracks — the same repair mechanism described above, triggered this time by a structural failure in the arterial wall rather than oxidative damage to the endothelium.
Humans lack the GLO enzyme that allows most animals to synthesise vitamin C internally, making the supply entirely dependent on dietary intake. Chronically low vitamin C — common in people eating low-vegetable diets or under sustained stress, which depletes vitamin C rapidly — creates a continuous source of arterial micro-damage that the cholesterol repair response then works to address. This is a distinct upstream driver that sits alongside the oxidative fat and homocysteine mechanisms, and one that rarely appears in standard cardiovascular risk discussions. Time-release vitamin C with rose hips and acerola provides sustained plasma levels through the day rather than the rapid excretion that standard vitamin C supplements produce.
Homocysteine from B vitamin depletion
Homocysteine is an intermediary in the methionine cycle. When B6, B12, and folate are adequate, homocysteine is rapidly converted to cysteine or remethylated to methionine. When these vitamins are depleted — by metformin, proton pump inhibitors, oral contraceptives, alcohol, or low dietary intake — homocysteine accumulates. Elevated homocysteine directly damages endothelial cells, creating the injury sites that LDL subsequently arrives to repair.
Homocysteine is a more consistent predictor of cardiovascular events than total LDL in several large prospective studies. Its elevation is entirely driven by identifiable, correctable nutrient deficiencies. It rarely appears in standard lipid panels.
Why Saturated Fat Is the Wrong Target
The original case against saturated fat came from Ancel Keys Seven Countries Study, published in 1970. The pharmaceutical implications became apparent in 1984, when the US National Cholesterol Education Program lowered the threshold for "high" cholesterol from 350 to 200 mg/dl. Overnight, millions of people with previously normal results became patients requiring treatment. The timing coincided with the commercial launch of the first statins. Keys correlated saturated fat intake with heart disease mortality across seven countries and found a positive association. Later analysis revealed Keys had data from 22 countries available and selected the seven that supported his hypothesis. The full 22-country dataset shows no consistent correlation.
One context where the conventional model retains genuine validity: familial hypercholesterolemia, a genetic condition affecting LDL receptor function, produces cardiovascular risk through a mechanism where LDL accumulation itself is a primary driver, independent of oxidative load. The oxidative damage model applies to the general population experiencing elevated LDL as a response to metabolic and dietary conditions — the clinical picture in people with inherited receptor defects requires separate consideration.
The subsequent dietary intervention trials attempted to validate the hypothesis by replacing saturated fat with polyunsaturated fat in the diet and measuring cardiovascular outcomes. The Minnesota Coronary Experiment, the Sydney Diet Heart Study, and the LA Veterans Trial all showed the same unexpected result: replacing saturated fat with polyunsaturated vegetable oils reduced LDL cholesterol but increased cardiovascular mortality. The cholesterol went down. The deaths went up.
These results were largely unpublished or buried for decades — the Minnesota data sat unreported for 40 years before being recovered and published in 2016.
The mechanism explains the findings. Saturated fats are chemically stable. Their carbon chains are fully saturated with hydrogen atoms, leaving no double bonds available for oxidation reactions. Butter, ghee, lard, and coconut oil heated to cooking temperatures generate minimal oxidation products. Seed oils, with their high polyunsaturated content, generate substantial oxidation products at the same temperatures.
Replacing stable saturated fat with unstable polyunsaturated fat reduced a marker (LDL) while worsening the underlying driver (oxidative load). The trials were measuring the wrong endpoint.
Vitamin K2 is one of the most overlooked nutrients in cardiovascular health. K2 activates Matrix Gla Protein (MGP) — a protein synthesised by vascular smooth muscle cells that binds calcium and prevents its deposition in arterial walls. MGP requires K2 for γ-carboxylation to become biologically active. Without adequate K2, MGP remains inactive, and calcium that should mineralise bone deposits in soft tissue and arterial walls instead. This is the specific mechanism behind the documented finding that arterial plaque is predominantly calcium — the body has the calcium but lacks the signal to direct it to bone rather than vessels. Restoring K2 through diet (fermented foods, organ meats, grass-fed animal fat) or supplementation activates MGP and supports the calcium routing that prevents arterial calcification. Vitamin K2 in MK-7 form has the longest half-life and most consistent research support for MGP activation.
What Shifts the Picture
The oxidative damage model is specific about what changes cardiovascular risk — and the answer centres on oxidative load rather than fat intake.
Replacing seed oils with stable fats removes the primary dietary source of oxidative load. Saturated and monounsaturated fats — butter, ghee, lard, tallow, olive oil, coconut oil — generate minimal oxidation products at cooking temperatures. The biggest seed oil exposure in a typical diet comes from restaurants, salad dressings, condiments, and packaged snacks. Home cooking oil is a smaller source than the label warnings suggest. Reading labels for soybean oil, sunflower oil, rapeseed oil, and corn oil covers the majority of hidden sources.
Correcting the omega-6 to omega-3 ratio reduces the pro-inflammatory eicosanoid production that drives chronic endothelial inflammation. This requires both reducing omega-6 intake (seed oils) and increasing omega-3 intake (fatty fish, grass-fed animal fat). The ratio matters as much as the absolute omega-3 number — people who add fish oil to a high seed oil diet see smaller benefits than people who replace seed oils and add fish oil simultaneously.
Controlling blood glucose reduces glycation of LDL and arterial wall proteins. Two interventions produce the most reliable results: eating protein before or alongside carbohydrate at meals (which blunts the glucose spike), and walking for ten minutes after eating (which activates muscle glucose uptake and flattens the post-meal curve). Both are achievable without any additional resources.
Magnesium glycinate supports both glucose metabolism and the glutathione synthesis the liver depends on for Phase II processing — two mechanisms that overlap directly with the oxidative damage model.
Correcting homocysteine through B vitamin adequacy removes a direct arterial injury driver. The people who specifically benefit from testing homocysteine: anyone taking metformin, proton pump inhibitors, or oral contraceptives (all of which deplete B12 or folate); vegans and long-term plant-based eaters; and anyone with a history of poor dietary variety. B12, B6, and folate from animal sources — liver, eggs, meat — or a methylated B-complex supplement address the depletion. The methylated forms bypass the conversion step that MTHFR genetic variants slow.
Increasing antioxidant capacity through cruciferous vegetables, polyphenol-rich foods, and Nrf2-activating compounds — the same pathway covered in the liver articles — reduces the oxidative stress that the entire repair cascade is responding to.
One genetic context worth knowing before applying these recommendations broadly: roughly 15-25% of the population carries the APOE4 allele, which affects LDL clearance and the inflammatory response to saturated fat. APOE4 carriers frequently see LDL rise more steeply on high saturated fat intake than the general population, and the metabolic picture behaves differently from the LMHR pattern described later. For APOE4 carriers, emphasising monounsaturated fats — olive oil, avocados — over saturated fat, while still eliminating seed oils, is the more appropriate application of the seed oil replacement principle. APOE genotyping is available through standard genetic testing and is worth knowing for anyone whose LDL responds unusually to dietary fat changes.
Every one of these interventions targets the conditions driving the LDL response. When those conditions improve, LDL typically normalises without pharmaceutical intervention. Repair demand falls. The response follows.
What a High Cholesterol Number Is Telling You
A high LDL result in isolation tells very little. The same number means different things depending on LDL particle size (small dense versus large buoyant), triglyceride levels (a marker of glucose metabolism and seed oil intake), HDL levels, oxidised LDL concentration, homocysteine, and inflammatory markers like hs-CRP.
The pattern that consistently predicts cardiovascular risk: high triglycerides, low HDL, high small dense LDL, elevated oxidised LDL, elevated homocysteine, elevated hs-CRP.
One pattern makes the limitation of total LDL number impossible to ignore. Lean, athletic people adopting ketogenic diets frequently develop dramatically elevated LDL — sometimes above 500 mg/dl — combined with high HDL and very low triglycerides. The pattern has a documented name: Lean Mass Hyper-Responders. The mechanism is specific: when glycogen stores are low and fat is the primary fuel, the liver produces more LDL particles to transport fatty acids to muscle and organ tissue. Research measuring coronary artery plaque directly via CT angiography in this population found no increased plaque formation compared to people with normal LDL levels. The same number that triggers statin prescriptions in a sedentary person with high triglycerides and low HDL carries entirely different metabolic meaning in a lean, metabolically healthy person on a low-carbohydrate diet. Total LDL conflates these two patterns into a single number and treats them identically.
Triglycerides deserve specific attention because the standard advice gets them backwards. Elevated triglycerides are driven primarily by carbohydrate excess and fructose — the liver converts surplus glucose and fructose into triglycerides for storage. Dietary fat has minimal effect on fasting triglyceride levels. People who adopt low-fat diets specifically to improve cardiovascular risk frequently see triglycerides rise and HDL fall — the exact combination the risk pattern above describes. The low-fat intervention worsens the markers that predict events while reducing the marker (total LDL) that predicts them poorly. Carbohydrate reduction and fructose elimination lower triglycerides reliably and rapidly, often within two to four weeks. This is the metabolic pattern of high oxidative load, high glucose flux, B vitamin depletion, and seed oil-dominant fat intake.
The pattern that predicts minimal cardiovascular risk despite high total LDL: large buoyant LDL particles, low triglycerides, high HDL, low oxidised LDL, normal homocysteine, low hs-CRP. This pattern is common in people eating animal-fat-dominant diets with low processed food intake.
The total LDL number obscures this distinction entirely. Someone with the second pattern on a statin to reduce their LDL has had their repair marker suppressed without any change to the underlying drivers. The damage continues. The repair response is pharmaceutically interrupted.
The cholesterol result worth taking seriously sits inside a broader panel that includes triglycerides, HDL, homocysteine, hs-CRP, and fasting glucose. That panel tells the actual story. Total LDL alone tells very little.
Most of these markers are absent from a standard lipid panel and need to be specifically requested. Homocysteine, hs-CRP, and fasting insulin are separate tests that many practitioners will add when asked. Apolipoprotein B (ApoB) or LDL particle number provides more clinically relevant information than total LDL calculated from the standard Friedewald equation. A triglyceride to HDL ratio below 2.0 is a useful proxy for LDL particle size when particle testing is unavailable — high triglycerides with low HDL indicates predominantly small dense LDL regardless of total LDL number. These are the questions worth bringing to a cardiovascular review.
For anyone who wants to move beyond markers entirely and see whether arterial damage is occurring, the Coronary Artery Calcium score (CAC) is the relevant test. A low-radiation CT scan measures calcified plaque directly in the coronary arteries. A score of zero means no calcified plaque is present — regardless of LDL level. A rising CAC score over time indicates active plaque accumulation. The CAC score answers the question the blood panel can only approximate: has the oxidative damage been happening long enough to produce structural arterial changes? A person with a CAC of zero and high LDL has a fundamentally different risk picture than a person with a high CAC and moderate LDL. Most standard cardiovascular workups never include it.
A BMJ Open analysis of existing studies found high LDL inversely correlated with all-cause mortality in the majority of people over 60 — those with higher LDL lived as long or longer than those with lower LDL. The finding is precisely what the oxidative damage model predicts: in the absence of the metabolic conditions that create arterial injury, higher cholesterol availability for repair, hormone production, and membrane maintenance carries no mortality penalty and may carry a benefit. The over-60 population is simultaneously the group most aggressively medicated with statins for elevated LDL.
The four-minute conversation that opens this story focuses on the number. The number is the least interesting part.
The cholesterol conversation spent fifty years focused on the wrong variable. Suppressing a repair marker while the damage driving it continues is a category error — sophisticated in execution and incomplete in strategy. The productive direction is the one the evidence consistently points toward: reduce the oxidative load, correct the nutrient deficiencies, restore the omega-6 to omega-3 ratio, control glucose flux. When those inputs change, cholesterol tends to follow without being targeted directly. Cholesterol is the message. The mistake was treating it as the problem.
The seed oils driving the oxidative damage at the centre of this story are covered in detail in two articles. Why Seed Oils Are Wrecking Your Health — and How They Got a Heart-Healthy Label Anyway — the full mechanism behind why linoleic acid oxidation products damage arterial tissue and why the heart-healthy label survived the evidence against it.
The inflammation driving endothelial injury has dietary triggers most people never connect to cardiovascular risk. Why Your Joints Hurt: The Inflammation Triggers Most People Never Address — the same chronic inflammatory drivers appear in joint pain and cardiovascular damage; the upstream causes are identical.
Know someone who has been told their cholesterol is too high and has been put on a low-fat diet? The mechanism behind why LDL rises changes what is worth addressing. Worth sharing with anyone whose cardiovascular advice has focused on the marker rather than what is driving it.
Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. Anyone with cardiovascular conditions or taking medications should consult a qualified healthcare provider before making dietary changes.
Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, we may earn a small commission at no additional cost to you. We only recommend products we consider genuinely relevant to the topics discussed.
